Ask a Question

User scenetimer35

Member for: 5 months (since Jun 22)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/pf-06826647.html
About: The phase 3 trial of safety, tolerability, and immunogenicity associated with V114, 15-valent pneumococcal conjugate vaccine, in contrast to 13-valent pneumococcal conjugate vaccine in older adults Fifty years of age and also older (PNEU-AGE).

Activity by scenetimer35

Score: 100 points (ranked #123)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for scenetimer35

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...